{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:19:46Z","timestamp":1775841586540,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ccm.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T17:13:40Z","timestamp":1573578820000},"page":"829-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Diagnostic Tests for Latent Tuberculosis Infection"],"prefix":"10.1016","volume":"40","author":[{"given":"Michelle K.","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Belknap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2019.07.007_bib1","series-title":"World Health Organization. Global tuberculosis report 2017","year":"2017"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence - United States, 2013-2015","volume":"65","author":"Salinas","year":"2016","journal-title":"MMWR Morb Mortality Wkly Rep"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15585\/mmwr.mm6711a2","article-title":"Tuberculosis - United States, 2017","volume":"67","author":"Stewart","year":"2018","journal-title":"MMWR Morb Mortality Wkly Rep"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib4","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis - United States, 2011-2014","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ccm.2019.07.007_bib5","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib7","doi-asserted-by":"crossref","first-page":"e0140881","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: prevalence estimates from the national health and nutrition examination survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2019.07.007_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev-publhealth-031912-114431","article-title":"Prospects for tuberculosis elimination","volume":"34","author":"Dye","year":"2013","journal-title":"Annu Rev Public Health"},{"issue":"9979","key":"10.1016\/j.ccm.2019.07.007_bib9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO's new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ccm.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(17)30248-7","article-title":"Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA","volume":"17","author":"LoBue","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2019.07.007_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(09)70326-3","article-title":"Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis","volume":"10","author":"Kranzer","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrmicro2236","article-title":"The spectrum of latent tuberculosis: rethinking the biology and intervention strategies","volume":"7","author":"Barry","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"9","key":"10.1016\/j.ccm.2019.07.007_bib13","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jama.1909.25420350001001","article-title":"Frequency of tuberculosis in childhood","volume":"LII","author":"Von Pirquet","year":"1909","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib14","first-page":"376","article-title":"Clemens von Pirquet: a remarkable life and career","volume":"6","author":"Shulman","year":"2017","journal-title":"J\u00a0Pediatric Infect Dis Soc"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/338149","article-title":"Evolution and current use of the tuberculin test","volume":"34","author":"Lee","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib16","first-page":"498","article-title":"Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results","volume":"12","author":"Menzies","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2019.07.007_bib17","first-page":"S221","article-title":"Targeted testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib18","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/clinids\/19.1.26","article-title":"Delayed-type hypersensitivity anergy in human immunodeficiency virus-infected persons screened for infection with Mycobacterium tuberculosis","volume":"19","author":"Huebner","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.1992.03480030047035","article-title":"Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users","volume":"267","author":"Graham","year":"1992","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","article-title":"QuantiFERON-TB gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases","volume":"33","author":"Bartalesi","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib22","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10238-009-0082-9","article-title":"Comparison of tuberculin skin test and QuantiFERON-TB gold in tube test in patients with chronic inflammatory diseases living in a tuberculosis endemic population","volume":"10","author":"Gogus","year":"2010","journal-title":"Clin Exp Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.idc.2018.05.002","article-title":"Prevention and management of tuberculosis in solid organ transplant recipients","volume":"32","author":"Epstein","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.ccm.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/infectious diseases Society of America\/Centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"4 Pt 1","key":"10.1016\/j.ccm.2019.07.007_bib26","first-page":"394","article-title":"The use of repeat skin tests to eliminate the booster phenomenon in serial tuberculin testing","volume":"123","author":"Bass","year":"1981","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.07.007_bib28","first-page":"232","article-title":"Modeling and correction of digit preference in tuberculin surveys","volume":"8","author":"Eilers","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"10.1016\/j.ccm.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"9235","key":"10.1016\/j.ccm.2019.07.007_bib30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","article-title":"Specific immune-based diagnosis of tuberculosis","volume":"356","author":"Andersen","year":"2000","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib31","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1128\/IAI.70.5.2544-2548.2002","article-title":"Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis","volume":"70","author":"Geluk","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of mycobacterium tuberculosis infection","volume":"27","author":"Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib33","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/JCM.02803-15","article-title":"Interferon gamma release assays for latent tuberculosis: what are the sources of variability?","volume":"54","author":"Banaei","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.ccm.2019.07.007_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00614-18","article-title":"Comparison of the QuantiFERON-TB gold plus and QuantiFERON-TB gold in-tube interferon gamma release assays in patients at risk for tuberculosis and in health care workers","volume":"56","author":"Theel","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00438-18","article-title":"Comparative evaluation of QuantiFERON-TB gold in-tube and\u00a0QuantiFERON-TB gold plus in diagnosis of latent tuberculosis infection in immunocompromised patients","volume":"56","author":"Ryu","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01688-18","article-title":"Higher positivity rate with fourth-generation QuantiFERON-TB gold plus assay in low-risk U.S. health care workers","volume":"57","author":"Hogan","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib38","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib39","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","article-title":"Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis","volume":"56","author":"Cattamanchi","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.ccm.2019.07.007_bib40","doi-asserted-by":"crossref","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-gamma release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0b013e3283474d62","article-title":"Interferon-gamma release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders","volume":"23","author":"Smith","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib42","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2012-201979","article-title":"You can't always get what you want, but if you try sometimes (with two tests--TST and IGRA--for tuberculosis) you get what you need","volume":"71","author":"Winthrop","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib43","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","article-title":"Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States","volume":"189","author":"Dorman","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.07.007_bib45","first-page":"1","article-title":"Serial testing with an interferon-gamma release assay in German healthcare workers","volume":"5","author":"Schablon","year":"2010","journal-title":"GMS Krankenhhyg Interdiszip"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib46","doi-asserted-by":"crossref","first-page":"518","DOI":"10.5588\/ijtld.17.0650","article-title":"Paradox of serial interferon-gamma release assays: variability width more important than specificity size","volume":"22","author":"Stout","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.ccm.2019.07.007_bib47","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-TB gold-plus in health care workers in a low-incidence setting","volume":"55","author":"Moon","year":"2017","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.ccm.2019.07.007_bib48","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5588\/ijtld.16.0764","article-title":"The sensitivity of the QuantiFERON((R))-TB Gold Plus assay in Zambian adults with active tuberculosis","volume":"21","author":"Telisinghe","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib49","doi-asserted-by":"crossref","first-page":"e0193589","DOI":"10.1371\/journal.pone.0193589","article-title":"Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting","volume":"13","author":"Konig Walles","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ccm.2019.07.007_bib51","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.5588\/ijtld.10.0631","article-title":"Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis","volume":"15","author":"Mandalakas","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2019.07.007_bib52","series-title":"Red Book: report of the Committee on Infectious Diseases, 2018-2021, 31st Edition","author":"Kimberlin","year":"2018"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib53","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2019.07.007_bib54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpeds.2018.04.034","article-title":"Interferon-gamma release assay-based screening for pediatric latent tuberculosis infection in an urban primary care network","volume":"200","author":"Gaensbauer","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"11","key":"10.1016\/j.ccm.2019.07.007_bib55","doi-asserted-by":"crossref","first-page":"e0142290","DOI":"10.1371\/journal.pone.0142290","article-title":"Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Ayele","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-gamma release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ccm.2019.07.007_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2019.07.007_bib58","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1473-3099(18)30355-4","article-title":"Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study","volume":"18","author":"Abubakar","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.ccm.2019.07.007_bib59","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents","volume":"186","author":"Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2019.07.007_bib60","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.clinthera.2012.03.006","article-title":"Utility of interferon-gamma release assay results to monitor anti-tubercular treatment in adults and children","volume":"34","author":"Chiappini","year":"2012","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1164\/rccm.201208-1352OC","article-title":"Interferon-gamma ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial","volume":"187","author":"Adetifa","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ccm.2019.07.007_bib62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)30436-2","article-title":"Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial","volume":"5","author":"Ruhwald","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.ccm.2019.07.007_bib63","doi-asserted-by":"crossref","first-page":"e0204554","DOI":"10.1371\/journal.pone.0204554","article-title":"C-Tb skin test to diagnose Mycobacterium tuberculosis infection in children and HIV-infected adults: a phase 3 trial","volume":"13","author":"Aggerbeck","year":"2018","journal-title":"PLoS One"},{"issue":"10035","key":"10.1016\/j.ccm.2019.07.007_bib64","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A\u00a0blood RNA signature for tuberculosis disease risk: a prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ccm.2019.07.007_bib65","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1164\/rccm.201711-2340OC","article-title":"Four-gene Pan-African blood signature predicts progression to tuberculosis","volume":"197","author":"Suliman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.07.007_bib66","doi-asserted-by":"crossref","first-page":"e183779","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of validity of a blood-based 3-gene signature score for progression and diagnosis of tuberculosis, disease severity, and treatment response","volume":"1","author":"Warsinske","year":"2018","journal-title":"JAMA Netw Open"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:58:09Z","timestamp":1759453089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523119300607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0272523119300607"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2019.07.007","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Tests for Latent Tuberculosis Infection","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}